New hope for anemic kids with failing kidneys
NCT ID NCT05682326
Summary
This study tested a drug called daprodustat to treat anemia (low red blood cells) in children and teenagers with chronic kidney disease. The main goals were to see how safe the drug was and if it could effectively raise hemoglobin levels over a year. It included a very small group of young patients, some on dialysis and some not.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Aichi, 466-8650, Japan
-
GSK Investigational Site
Saitama, 330-8777, Japan
-
GSK Investigational Site
Tokyo, 162-8666, Japan
-
GSK Investigational Site
Yangsan, 50612, South Korea
Conditions
Explore the condition pages connected to this study.